We Are Here

Core Members

Expertise in drug discovery, chemical biology, target identification and validation
Specialized in “undruggable” drug discovery field
Ph. D. in Organic Chemistry; Postdoc in Harvard Medical School
Investigator in Novartis for 5 years
Independent Principle Investigator in the Chinese Academy of Sciences for 7 years

Over 20 years of experience in tumor clinical treatment and clinical research of antitumor drugs
Member of Chinese Preventive Medicine Association
Served as senior management team and led clinical teams in many multinational pharmaceutical companies, including GSK, Novartis, Hutchison Whampoa, etc
Ex-member of the R&D Executive Committee and Ex-Vice Chairman of Medical Affairs of RDPAC
Graduated from Capital Medical University and University of Waterloo, Canada

Over 15 years of experience in biopharmaceutical and medical health industry and investment
Served in Cell Genesys in San Francisco and Shire HGT in Boston, responsible for the development of cellular drugs and protein drugs
Served in Pfizer, AstraZeneca and Roche, led the company's R&D business development and project management in Greater China
Bachelor of chemical engineering from Tsinghua University; Ph.D of chemical and biological engineering from Northwestern University

Over 10-year professional experience in legal, risk management and capital market for Pharma industry
Served in multi-national consulting firms and big Pharma company, including Novartis and E&Y
Received Bachelor in law from Fudan University and Master in Commerce from University of New South Wales, Australia
Received Chinese Bar Qualification and Certified International Internal Auditor

Member of the National Academy of Sciences (US)
Member of the American Academy of Arts and Sciences
Fellow of the American Academy of Arts and Sciences
Published more than 220 academic papers, in major journals including Nature, Science and Cell, with more than 93,000 citations
A pioneer and leading scientist in Cell Death field

A team of R&D experts with experience in multinational pharma companies

Staying on top of the technology and driving excellent execution